United States · FDA National Drug Code directory
Spironolactone and Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 66993-188_eca75090-9808-4673-bd7e-1ecd571d3b3e
- Product NDC
- 66993-188
- Form
- TABLET, FILM COATED
- Composition / generic term
- spironolactone and hydrochlorothiazide
- Labeler
- Prasco Laboratories
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20211129
- Source listing expiry
- 20271231
Source-listed ingredients
- SPIRONOLACTONE — 25 mg/1
- HYDROCHLOROTHIAZIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (66993-188-02) · 66993-188-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →